Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cerilliant
Citi
Federal Trade Commission
US Department of Justice
Moodys
Daiichi Sankyo
AstraZeneca
Medtronic

Generated: May 22, 2018

DrugPatentWatch Database Preview

ACTIMMUNE Drug Profile

« Back to Dashboard

Summary for Tradename: ACTIMMUNE
Patents:35
Applicants:1
BLAs:1
Suppliers: see list2
Pharmacology for ACTIMMUNE
Ingredient-typeInterferon-gamma

US Patents for ACTIMMUNE

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Vidara Therapeutics Research Ltd ACTIMMUNE interferon gamma-1b VIAL; SINGLE-USE 103836 001 1999-02-25 ➤ Sign Up REPLICOR INC. (Montreal, CA) ➤ Sign Up RX search
Vidara Therapeutics Research Ltd ACTIMMUNE interferon gamma-1b VIAL; SINGLE-USE 103836 001 1999-02-25 ➤ Sign Up PEG Biosciences, Inc. (Monmouth Junction, NJ) ➤ Sign Up RX search
Vidara Therapeutics Research Ltd ACTIMMUNE interferon gamma-1b VIAL; SINGLE-USE 103836 001 1999-02-25 ➤ Sign Up Idenix Pharmaceuticals LLC (Cambridge, MA) ➤ Sign Up RX search
Vidara Therapeutics Research Ltd ACTIMMUNE interferon gamma-1b VIAL; SINGLE-USE 103836 001 1999-02-25 ➤ Sign Up Infinity Pharmaceuticals, Inc. (Cambridge, MA) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for ACTIMMUNE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2014000079 Germany ➤ Sign Up PRODUCT NAME: SOFOSBUVIR UND PHARMAZEUTISCH AKZEPTABLE SALZE DAVON; REGISTRATION NO/DATE: EU/1/13/894 20140116
00681 Netherlands ➤ Sign Up PRODUCT NAME: SOFOSBUVIR, DESGEWENST IN DE; REGISTRATION NO/DATE: EU/1/13/894/001-002 20140116
2014 00041 Denmark ➤ Sign Up PRODUCT NAME: SOFOSBUVIR; REG. NO/DATE: EU/1/13/894/001-002 20140116
513 Luxembourg ➤ Sign Up PRODUCT NAME: SOFOSBUVIR ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (SOVALDI). FIRST REGISTRATION: 20140117
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Baxter
Johnson and Johnson
Teva
McKinsey
Julphar
US Department of Justice
Fish and Richardson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.